Structure |
Chemical Name |
CAS |
MF |
|
Nilotinib Hydrochloride Monohydrate |
923288-90-8 |
C28H25ClF3N7O2 |
|
4-Morpholinyl(4,5,6,7-tetrahydro-1H-pyrazolo-[4,3-c]pyridin-3-yl)methanone hydrochloride |
1220027-05-3 |
C11H17ClN4O2 |
|
2-(Diethylamino)-N'-hydroxybenzenecarboximidamide |
1021244-00-7 |
C11H17N3O |
|
4-amino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid |
130525-62-1 |
C11H18N2O7 |
|
4-(4-HYDROXYPHENYL)BUTANOIC ACID |
7021-11-6 |
C10H12O3 |
|
4-Fluoro-1H-pyrazole |
35277-02-2 |
C3H3FN2 |
|
METHYL 1H-PYRAZOLE-4-CARBOXYLATE |
51105-90-9 |
C5H6N2O2 |
|
2-(2-HYDROXYPHENYL)-4H-1,3-BENZOXAZIN-4-ONE |
1218-69-5 |
C14H9NO3 |
|
Fmoc-Thr-Obzl |
73724-48-8 |
C26H25NO5 |
|
3-(Dimethylamino)-1-(3-methoxyphenyl)-2-methyl-1-propanone hydrochloride |
37951-53-4 |
C13H20ClNO2 |
|
tert-butyl (R)-4-(((tert-butyldimethylsilyl)oxy)methyl)-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide |
|
|
|
9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
211105-29-2 |
C20H28D4O5 |
|
(S)-3-PHENYL-BETA-ALANINOL HCL
|
936499-93-3 |
C9H14ClNO |
|
Entecavir hydrate |
|
|
|
Hydantoin |
461-72-3 |
C3H4N2O2 |
|
3-Iodo-6-nitroindazole |
70315-70-7 |
C7H4IN3O2 |
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
2243785-98-8 |
C37H42F2N8O4 |
|
17-PHENYL TRINOR PROSTAGLANDIN E2 |
38315-43-4 |
C23H30O5 |
|
1-Boc-2,5-Dihydro-1H-pyrrole-3-boronic acid, pinacol ester |
212127-83-8 |
C15H26BNO4 |
|
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol |
153004-31-0 |
C32H47F5O2S |
|
(1R,4S,4aR,9aS)-rel-1,4,4a,9a-Tetrahydro-4a-methyl-1,4-methanoanthracene-9,10-dione |
97804-50-7 |
C16H14O2 |
|
6-Chloro-1H-pyrazolo[4,3-c]pyridine |
1206979-33-0 |
C6H4ClN3 |
|
TFA-ap-dC |
115899-38-2 |
C14H15F3N4O5 |
|
(alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride |
521284-22-0 |
C16H21ClN2O |
|
(R)-tert-butyl 4-(4-(6-aMino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate |
877399-51-4 |
C26H30Cl2FN5O3 |
|
6-(4-Chlorophenyl)-2,3-Dihydro-2,2-DiMethyl-7-Phenyl-1H-Pyrrolizine |
133111-56-5 |
C21H20ClN |
|
3-Iodo-1H-pyrazole-4-carbonitrile |
827316-44-9 |
C4H2IN3 |
|
CarbaMic acid, [(1S)-3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl ester (9CI) |
247068-81-1 |
C14H25NO3 |
|
(R)-1-acetyl-5-[2-(phenylsulfonyl)ethyenyl]-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole |
180637-88-1 |
C24H26N2O3S |
|
Posaconazole EnantioMer |
|
|
|
(αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanoic Acid |
483340-19-8 |
C13H13F2N3O3 |
|
B-[2-(9H-Carbazol-9-yl)phenyl]boronic acid |
1189047-28-6 |
C18H14BNO2 |
|
PROSTAGLANDIN D2 |
41598-07-6 |
C20H32O5 |
|
Vc-seco-DUBA |
1345681-58-4 |
C65H75ClN12O17 |
|
Deruxtecan |
1599440-13-7 |
C52H56FN9O13 |
|
3-cinnamoyl-4-hydroxy-2H -chromen-2-one |
209973-90-0 |
C18H12O4 |
|
Sugammadex sodium 7-Bromide intermediates |
|
|
|
Oseltamivir Glucose Adduct 1 |
|
|
|
(3R,5R,2R,3S)-posaconazole |
|
|
|
7-HYDROXY-4-PHENYLCOUMARIN 97 |
2555-30-8 |
C15H10O3 |
|
ditert-butyl pyrrolidine-1,2-dicarboxylate |
347189-18-8 |
C14H25NO4 |
|
Remdesivir No. 5 intermediate |
|
|
|
Dextran Standard D0 |
|
|
|
Cefotifuromercapto |
|
|
|
tert-butyl 2-(5-bromo-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonane-7-carboxylate |
|
|
|
BENZOIC ACID, 2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-3-NITRO-METHYL ESTER |
57113-90-3 |
C13H16N2O6 |
|
tert-butyl (S)-(1,3-dihydrospiro[indene-2,4'-piperidin]-1-yl)carbamate |
2377357-06-5 |
C18H26N2O2 |
|
4-Oxazolecarboxylic acid, 5-amino-, methyl ester |
63820-04-2 |
C5H6N2O3 |
|
2-Piperidineacetic acid, α-(4-methylphenyl)-, methyl ester |
191790-79-1 |
C15H21NO2 |
|
(9H-fluoren-9-yl)methyl (R)-(1-(methylamino)-1-oxo-3-(pyridin-4-yl)propan-2-yl)carbamate |
|
|
|
(9H-fluoren-9-yl)methyl (S)-(1-cyclohexyl-2-(methylamino)-2-oxoethyl)carbamate |
|
|
|
endo-8-isopropyl-8-azabicyclo[3.2.1]octan-3-ol |
3423-25-4 |
C10H19NO |
|
Cephalexin Tablets |
|
|
|
Pluronic PE 4300 |
|
|
|
3-Azabicyclo[3.1.0]hexane-1,3-dicarboxylic acid, 3-(1,1-dimethylethyl) 1-ethyl |
1204820-62-1 |
C13H21NO4 |
|
4-Chloro-benzenesulfonic acid 5-(2,4-difluoro-phenyl)-5-[1,2,4]triazol-1-ylMethyl-tetrahydro-furan-3-ylMethyl ester |
175712-02-4 |
C20H18ClF2N3O4S |
|
2-(methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate |
1180002-01-0 |
C15H23N3O4 |
|
Coumarin |
6160-02-7 |
C19H19NO2 |
|
4,4'-(Hexafluoroisopropylidene)diphthalic anhydride |
1107-00-2 |
C19H6F6O6 |
|
Nevirapine intermediate |
|
|
|
Fluvis group intermediate |
|
|
|
8-Methylene-1,4-dioxa-spiro[4.5]decane |
51656-90-7 |
C9H14O2 |
|
(3R,4S,5S)-Oseltamivir |
|
|
|
1(2H)-Pyridinecarboxylic acid, 2-(aminocarbonyl)-5-[[(1,1-dimethylethoxy)carbonyl]hydroxyamino]-5,6-dihydro-3-methyl-, 1,1-dimethylethyl ester, (2S,5R)- |
2209872-72-8 |
C17H29N3O6 |
|
INDEX NAME NOT YET ASSIGNED |
2070009-39-9 |
C35H39N5O10 |
|
(9H-fluoren-9-yl)methyl ((2S,3R)-3-hydroxy-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
|
Etodesnitazene |
14030-76-3 |
C22H29N3O |
|
1,4-BIS-[4-(6-ACRYLOYLOXYHEXYLOXY)BENZOYLOXY]-2-METHYLBENZENE |
125248-71-7 |
C39H44O10 |
|
(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one |
156732-13-7 |
C32H32N2O |
|
pinanyl hydroperoxide |
28324-52-9 |
C10H18O2 |
|
iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide |
76247-39-7 |
C9H12INO5S |
|
Intermediate 1 |
2203433-07-0 |
C17H16N2O5 |
|
8-bromoxanthosine |
3001-46-5 |
C10H11BrN4O6 |
|
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
1062580-52-2 |
C14H23ClN2 |
|
Amic acid |
|
|
|
(3R)-3-dodecanoyloxy-4-trimethylammonio-butanoate |
25518-54-1 |
C19H37NO4 |
|
ATORVASTATIN SODIUM |
134523-01-6 |
C33H36FN2NaO5 |
|
N(4)-methylcytidine |
10578-79-7 |
C10H15N3O5 |
|
qianhucoumarin A |
150135-35-6 |
C19H20O6 |
|
Ethyl N-Cbz-4-Oxopyrrolidine-3-carboxylate |
51814-19-8 |
C15H17NO5 |
|
lupinine hydrochloride |
6113-09-3 |
C10H20ClNO |
|
METHYL ESTER, 4,5-BIS(2-METHOXYETHOXY)-2-NITROBENZOIC ACID |
501684-22-6 |
C14H19NO8 |
|
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate |
179324-87-9 |
C17H29BF3NO4 |
|
TERT-BUTYL 3-BROMO-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE-7(8H)-CARBOXYLATE |
723286-80-4 |
C10H15BrN4O2 |
|
6-[[[4-[(1-Oxo-2-propen-1-yl)oxy]butoxy]carbonyl]oxy]-2-naphthalenecarboxylic acid 2,2'-[2-(methoxycarbonyl)-1,4-phenylene] ester |
914918-26-6 |
C46H40O16 |
|
Methyl 1-(MethylaMino)cyclobutanecarboxylate hydrochloride |
1247180-93-3 |
C7H13NO2 |
|
Tert-Butyl(1R,2S,5S)-2-azido-5-[(dimethylamino)carbonyl]cyclohexylcarbamate oxalic acid |
1353893-22-7 |
C16H29N3O7 |
|
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester |
112811-71-9 |
C16H15F2NO4 |
|
tert-butyl 3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxylate |
1246551-25-6 |
C11H19N3O3 |
|
Velpatasvir intermediate |
1378391-43-5 |
C44H55N3O13 |
|
Safinamide-d4 |
1147299-69-1 |
C17H19FN2O2 |
|
tert-butyl 4-(chloromethyl)-4-(hydroxymethyl)piperidine-1-carboxylate |
1312131-45-5 |
C12H22ClNO3 |
|
Posaconazole Diastereoisomer 12 |
213381-04-5 |
C37H42F2N8O4 |
|
tert-butyl(R)-3-((6-chloropyrazin-2-yl)oxy)piperidine-1-carboxylate |
1147998-31-9 |
C14H20ClN3O3 |
|
1-[4-Bromo-3-(bromomethyl)phenyl]ethanone |
1844064-91-0 |
C9H8Br2O |
|
3-Aminopyrazole |
1820-80-0 |
C3H5N3 |
|
Cefuroxime double mother nucleus |
|
|
|
6α,9α-difluoro-17α-(furan-2-yl)carbonyloxy-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioic acid |
397864-40-3 |
C26H28F2O6S |
|
Derivatives intermediate 2 |
1213710-57-6 |
C26H38N2O3 |
|
Lixivaptan intermediate-IV |
179063-21-9 |
C19H14ClN3O3 |